Despite the special working environment and exposures of airline pilots, data on risk of death and cancer incidence in this occupational group are limited. The authors investigated a cohort of 2,740 Air Canada pilots who contributed 62,449 person-years of observation. All male pilots employed for at least 1 year on and since January 1,1950, were studied. The cutoff date for outcome information was December 31,1992. Standardized mortality ratio (SMR) and standardized incidence ratio (SIR) were used to compare mortality rates and cancer incidence rates of the cohort with the respective Canadian population rates. Ninety percent confidence intervals of the SMR and SIR were calculated. Statistically significant decreased mortality was observed for all causes (SMR = 0.63, 90% confidence interval (Cl) 0.56-0.70), for all cancers (SMR = 0.61, 90% Cl 0.48-0.76), and for all noncancer diseases (SMR = 0.53, 90% Cl 0.45-0.62). Mortality from aircraft accidents was significantly raised (SMR = 26.57,). Significantly decreased cancer incidence was observed for all cancers (SIR = 0.71, 90% Cl 0.61-0.82), rectal cancer (SIR = 0.42, 90% Cl 0.14-0.96), lung cancer (SIR = 0.28, 90% Cl 0.16-0.46), and bladder cancer (SIR = 0.36, 90% Cl 0.12-0.82). Prostate cancer (SIR = 1.87, 90% Cl 1.38-2.49) and acute myeloid leukemia (SIR = 4.72, 90% Cl 2.05-9.31) were significantly increased. The preferred relative risk model for radiation-induced nonchronic lymphoid leukemia (Beir V report) was applied to the cohort by using published estimates of in-flight radiation exposures. The estimated relative risk ranged from 1.001 to 1.06 and did not differ significantly from the observed SIR (SIR = 1.88, 90% Cl 0.80-3.53). However, the incidence rate of acute myeloid leukemia was significantly increased. Monitoring of in-flight radiation exposure and long-term follow-up of civil aviation crew members is needed to further assess cancer incidence and leukemia risk in this special occupational group. Am J Epidemiol 1996;143:137-43. aviation; leukemia; mortality; neoplasms; risk Civil aviation crew members are exposed to known or suspected physical and chemical carcinogens or mutagens, particularly ionizing radiation, ozone, and jet engine emissions (1-4). Despite the special working environment and exposures of airline pilots, data on risk of death and cancer incidence in this occupational group are limited. Death certificate studies have reported increased proportional mortality ratios for deaths due to aircraft accidents (5-8); for rectal (5), colon (8), prostate (8), and brain cancers (8); and for malignant melanoma (8) and decreased proportional Received for publication December 12, 1994, and in final form October 26, 1995. Abbreviations: AML, acute myeloid leukemia; Cl, confidence interval; CLL, chronic lymphoid leukemia; SIR, standardized incidence ratio; SMR, standardized mortality ratio.
Civil aviation crew members are exposed to known or suspected physical and chemical carcinogens or mutagens, particularly ionizing radiation, ozone, and jet engine emissions (1) (2) (3) (4) . Despite the special working environment and exposures of airline pilots, data on risk of death and cancer incidence in this occupational group are limited. Death certificate studies have reported increased proportional mortality ratios for deaths due to aircraft accidents (5) (6) (7) (8) ; for rectal (5) , colon (8) , prostate (8) , and brain cancers (8) ; and for malignant melanoma (8) and decreased proportional mortality ratios for deaths due to atherosclerotic heart (5-8) and respiratory (5, 7, 8) diseases. Proportional mortality studies are limited by inaccuracies of cause of death certification (9) , and within a single occupational group, markedly high or low proportional mortality ratios for common causes of death may affect these ratios for less common causes including cancer (5) .
In the first published cohort study of airline pilots of which we are aware, we reported excess relative rates for mortality due to aircraft accidents and rectal and brain cancers and decreased mortality risks from atherosclerotic heart diseases, as well as increased relative incidence rates for brain cancer and Hodgkin's disease (10) . These results were based on a small cohort; few incident cancer cases were observed, risk estimates showed wide confidence intervals, and it was concluded that caution needed to be exercised in interpreting the data. In this paper, we report mortality and cancer incidence rates in a different and larger cohort of airline pilots. 138 Band et al.
MATERIALS AND METHODS

Subject characteristics and data collection
All male pilots employed by Air Canada for 1 year or more on and since January 1, 1950 , were included in this study. Completeness of the cohort enumeration was ensured by a thorough search of the company's employee records. The following information was obtained from the company records: full name, date of birth, social insurance number, date of first hire, date of termination of employment, and current or last known address and telephone number. For pilots no longer employed whose current addresses were unknown to the company, information was sought from active pilots, the Canadian Air Line Pilots Association, government authorities responsible for issuing driver's licenses, the Ministry of Transport of Canada, and various other sources. Cause and date of death and cancer incidence information, including date of diagnosis, site, and histology, were ascertained through the Divisions of Vital Statistics and the Cancer Registries of the Canadian Provinces, the Canadian Mortality Data Base, Air Canada medical records, the pilots' pension plan, hospitals, and physicians' offices. The cutoff date for outcome information was December 31, 1992.
Statistical procedure
Analyses for mortality and cancer incidence were carried out separately. For mortality rates, personyears at risk were calculated from 1 year after the date of hire to December 31, 1992, or to the year of death, whichever came first. For cancer incidence rates, person-years at risk were calculated from 1 year after the date of hire to December 31, 1992 , to the year of cancer diagnosis, or to the year of death from noncancer causes, whichever came first. For pilots lost to follow-up, observations were censored at the date when last known to be alive.
Standardized mortality ratios (SMRs) and standardized cancer incidence ratios (SIRs) were used to compare the mortality and cancer incidence of the cohort with those of the Canadian male population. Canadian population mortality rates, obtained from the Laboratory Centre for Disease Control, Health Canada, were calculated by 5-year age groups and 5-year calendar periods dating back to 1950, with the rates for 1985-1989 being used for the period 1990-1992. Similarly, Canadian cancer incidence rates were obtained from the Laboratory Centre for Disease Control by the same 5-year age groups and calendar periods for the years 1969-1988. Incidence rates for the years prior to 1969 were estimated by the 1969-1973 incidence rates, and rates for 1989-1992 by the incidence rates for [1984] [1985] [1986] [1987] [1988] . Tests of significance and of the SMRs and SIRs were calculated assuming the observed number of events followed a Poisson distribution with mean given by the expected number of events (11) . To facilitate data comparison with our previous study (10) , one-sided t test and 90 percent confidence intervals corresponding to a 5 percent significance level were used. Incidence ratios for nonmelanoma skin cancer could not be calculated since national rates for this cancer are not available. During the study period, causes of death were coded according to four versions of the International Classification of Diseases, Sixth, Seventh, Eighth, and Ninth Revisions. All codes for both causes of death and cancer incidence were reconciled to the Ninth Revision (12) .
Estimation of leukemia risk due to in-flight radiation exposure
The number of leukemia cases in the cohort expected to be due to ionizing radiation exposure was calculated by using exposure estimates from Friedberg et al. (13) . Friedberg et al. estimated the radiation doses to the bone marrow during conditions of average solar activity received by aircraft crew members for various flight paths originating or terminating in the United States. These authors estimated exposures ranging between 0.2 milliSievert (mSv) to 9.1 mSv per working year for crew members flying these paths. Data on current flight patterns for Air Canada pilots, obtained from Air Canada, showed the following breakdown of proportional flight hours for the overall pilot cohort: 1) within Canada, 53 percent; 2) CanadaUnited States, 18 percent; 3) Canada-Europe, 16 percent; 4) elsewhere and charter flights: 13 percent. Taking a New York-to-Chicago flight (13) to be representative of categories 1 and 2 gave an estimated annual dose of 5 mSv for flights in these categories. Taking a Chicago to London flight to be representative of categories 3 and 4 yielded an estimated annual dose of 7 mSv. Weighting these estimates by the overall proportion of time spent flying in categories 1-4 gave a mean exposure of 5.6 mSv per year per pilot in the cohort. Since it is expected that exposures for Canadian pilots would be slightly higher because of the more northerly latitude and probable longer average flight duration, this number was rounded up to 6.0 mSv per year. Data from in-flight measurements made in Lufthansa airplanes at altitudes ranging between 10 km (33,000 feet) and 11.1 km (37,000 feet) (14) led to similar estimates of exposures, ranging between 3 and 5 mSv per working year. For each pilot, total doses of ionizing radiation by age were calculated by using the person-years method for the period of employment. The preferred relative risk model for radiation-induced leukemia mortality from the BEIR V report (15) was then applied to the cohort by using the estimated exposures to obtain the expected number of cases of leukemia excluding chronic lymphoid leukemia (CLL) (15) . It was assumed that the relative risks for radiation-induced leukemia mortality applied to leukemia incidence. To derive an estimated range of risks, we also used the lowest and highest amounts of annual radiation exposure reported by Friedberg et al., 0.2 and 9.1 mSv, respectively (13) .
RESULTS
A total of 2,740 eligible pilots were identified, of whom 2,680 were successfully traced (97.8 percent). The characteristics and person-year distribution of the cohort are shown in tables 1 and 2, respectively. As of December 31, 1992, 219 pilots had died, 81 (37 percent) from cardiovascular conditions, 56 (26 percent) from cancer, 31 (14 percent) from aircraft accidents, and 51 (23 percent) from other causes (table 3). All causes of death were confirmed. A total of 125 cancer incident cases, excluding 106 cases of nonmelanoma skin cancer, were ascertained (table 4); one pilot had two synchronous cancers (a transitional cell carcinoma of the bladder and an adenocarcinoma of the kidney). All cancers were histologically confirmed and, except for three (one brain tumor, one colon cancer, and one acute myeloid leukemia diagnosed in 1952, 1960, and 1964, respectively), were diagnosed in 1969 or later. All brain tumors were astrocytomas (three grade II; four grades III and IV). Seven of the nine leukemias were myeloid leukemias, and of these, six were acute myeloid leukemias (AML). SMRs and SIRs for dis- eases with two or more deaths or cancer incident cases are shown in tables 3 and 4, respectively. SMRs (table  3) were significantly decreased statistically for all causes of death; for all cancers combined; and for deaths due to cardiovascular, respiratory, and digestive diseases, nonaircraft accidents, and lung cancer and were significantly increased for deaths due to aircraft accidents. Elevated SMRs were observed for malignant melanoma of the skin and for prostate and brain cancers. SIRs (table 4) The preferred leukemia model from the BEIR V report (15) , which excludes CLL, applied to the cohort gave an estimated expected number of cases of 3.87 for all non-CLL, assuming a mean annual dose of 6 mSv per pilot in the cohort and expected numbers of cases of 3.73 and 3.94 assuming mean annual doses of 0.2 mSv and 9.1 mSv, respectively. In the absence of radiation exposure, the expected number of cases of non-CLL was 3.72 (table 4); the estimated expected excess of non-CLL cases attributed to in-flight radiation exposure is therefore 0.01, 0.15, and 0.22 for the mean annual dose estimates of 0.2, 6.0, and 9.1 mSv, respectively. The estimated average relative risks of the cohort for non-CLL due to radiation exposure corresponding to these mean annual doses are 1.001, 1.04, and 1.06. These relative risks fall within the 90 percent confidence interval for non-CLL (table 4) .
DISCUSSION
The cohort of Air Canada pilots described in this report comprises over three times the numbers and person-years of follow-up of a different cohort of Canadian Pacific Airlines pilots previously published (10). This study confirms our previous findings of statistically significant decreased death rates from all causes and from cardiovascular and respiratory diseases. These results are consistent with those from mortality studies (5) (6) (7) (8) and reflect the healthy worker effect of this occupational group highly selected for their health and physical fitness. The marked increased mortality from aircraft accidents noted in this study is comparable in magnitude with previously reported observations from different commercial airlines (8, 10) and from mortality studies (5-7) and likely represents a hazard specific to the occupation. Our study also confirms the statistically significant decreased incidence of all cancers, mostly attributable to the markedly reduced lung and bladder cancer rates, which strongly suggests that pilots smoke less than does the general population. The increased SMR and SIR noted for brain cancer, calculated on mortality and incidence rates for all malignant brain tumors, did not reach statistical significance as previously observed (10) , although the confidence interval from both studies overlapped and did not show any time-related effects. All brain tumors reported in this study and in our previous study were astrocytomas. SIR based on astrocytoma-and glioblastoma-(astrocytomas grades HI and IV) specific rates showed an almost twofold excess (table 4) . The elevated rectal cancer mortality rate (10) was not corroborated in this study; excess risk for rectal cancer had also been reported in one mortality study (5), but not in others (6) (7) (8) . Reasons for these discrepancies are not readily apparent but may be related to chance variation due to small numbers. Similarly, the increased Hodgkin's disease incidence rate seen in the Canadian Pacific Airlines cohort (relative risk = 4.54 based on three observed cases) was not confirmed.
The main new findings of this study are the statistically significant increased relative incidence rates of prostate cancer and AML. The etiology of prostate cancer is unknown; aside from certain occupational risks, notably farming, a high intake of animal fat has been suggested as the main potential risk factor (16) . The latter possibility seems unlikely in our study, since one would not expect an increased consumption of animal fat to be associated with a markedly reduced mortality from atherosclerotic heart disease. Detection bias might be a more likely explanation, since throughout their career pilots must undergo yearly physical examinations, including a digital rectal examination. However, the mortality rate from prostate cancer was elevated, but not significantly so, and in a study of British Airways pilots excess deaths from prostate cancer were observed (8) .
The epidemiology of acute leukemias has been addressed in several recent reviews (17) (18) (19) . Among the risk factors associated with these diseases, exposures to ionizing and nonionizing radiation and benzene require special consideration. Benzene is a known human leukemogen, predominantly causing AML (19, 20) , and is present in low concentrations in jet fuel (21) and jet fuel vapors (22) . However, evidence of the carcinogenicity to humans of jet fuel is inadequate (21) , and a recent cohort of workers exposed to jet fuel did not reveal any increased leukemia risk (23) . Epi-demiologic studies have provided some evidence of an association between acute leukemia, particularly AML, and exposure to 50/60 Hz electromagnetic field (19, (24) (25) (26) . Airline pilots are exposed to electromagnetic fields ranging from 400 Hz to several thousand gigahertz. Whether such exposures may play a role in the elevated AML risk observed in our study remains hypothetical.
Exposure to ionizing radiation is a well-known cause of all types of leukemia except CLL (15, 18, 19) . Pilots are exposed to cosmic radiation, to periodic solar flares during which cosmic dose rates are substantially increased (27) (28) (29) (30) , and to radioactive material that may be transported as cargo (27) . This occupational exposure may exceed the radiation dose limits recommended for the general population and has led to the suggestion that commercial aviation crew members be considered as radiation workers (28) (29) (30) .
By applying the preferred leukemia mortality relative risk model to leukemia incidence, we estimated that the expected excess of non-CLL experienced in the cohort is between 0.01 and 0.22 cases over the entire study period. Application of this model involves the assumption that survival for radiation-induced leukemia is similar to that for leukemia not induced by radiation. Uncertainties also exist in the way in which we have estimated cumulative radiation doses. First, the radiation doses reported by Friedberg et al. (13) do not take into account solar proton events during which radiation dose rates may be considerably increased or exposure from transportation of radioactive material. In addition, radiation doses received by pilots would show great variation, but data on individual exposures are not available. The change from propeller-driven aircraft to jets in the early 1960s, with the concomitant gain in cruising altitude and radiation exposure and the assumption that pilots were flying the same number of hours annually in the past as currently would suggest that we may have overestimated past exposure; such overestimate is unlikely to be large since only 9 percent of the cohort's total person-year distribution accumulated prior to 1960.
Our study found no statistically significant excess for non-CLL, and not all subtypes of leukemias associated with radiation exposure were observed. However, the incidence rate for AML, the leukemia type most strongly associated with radiation exposure (15, 18) , significantly exceeded the expected number. It is of interest to note that AML was also the main type of non-CLL found among British Airways (8) and Canadian Pacific Airlines (10) pilots. The SIRs observed in our study for AML increased with time since first employment and with duration of employment; because of small numbers, these time-related effects should be interpreted with caution. No definite explanation for this excess risk can be provided at this time. Although a chance occurrence cannot be excluded, a synergistic effect between known or suspected leukemogens remains a possibility (31) . Monitoring of inflight radiation exposure as well as long-term follow-up of cohorts of civil aviation crew members is needed to further assess cancer incidence, particularly brain cancer (8, 10) and leukemia risk, in this special occupational group.
